Kamada Ltd Sustainability Reports
Kamada Ltd. is a commercial-stage plasma-derived biopharmaceutical company that develops, manufactures, and commercializes specialty protein therapeutics for orphan indications. Its operations focus on proprietary extraction and purification platform technologies to produce therapies such as Alpha-1 Antitrypsin (AAT) and various hyper-immune globulins.
Sector: Manufacturing
Country: Israel
Exchange: Tel Aviv Stock Exchange
FIGI: BBG001SFD0K6
2 reports from 2021 to 2023
